Resection of malignant brain tumors in eloquent cortical areas: A new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring

Journal of Neurosurgery

Volumn 113, Issue 2, 2010, Pages 352-357

  Feigl, Guenther C ^a   Ritz, Rainer ^a   Moraes, Mario ^a   Klein, Jan ^b   Ramina, Kristofer ^a   Gharabaghi, Alireza ^a   Krischek, Boris ^a   Danz, Soeren ^a   Bornemann, Antje ^a   Liebsch, Marina ^a   Tatagiba, Marcos S ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b FRAUNHOFER MEVIS   (Germany)

Author keywords

Cortical stimulation; Fiber tracking; Fluorescence guided tumor resection; Neuronavigation; Primary malignant brain tumor

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; BRAIN CANCER; BRAIN CORTEX; CANCER GROWTH; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DIFFUSION TENSOR IMAGING; FEMALE; HEMIPARESIS; HOMONYMOUS HEMIANOPIA; HUMAN; INTRAOPERATIVE PERIOD; KARNOFSKY PERFORMANCE STATUS; MALE; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; STIMULATION; THALAMOCORTICAL TRACT;

ADULT; AGED; AMINOLEVULINIC ACID; ASTROCYTOMA; BRAIN NEOPLASMS; CEREBRAL CORTEX; COMBINED MODALITY THERAPY; DIFFUSION TENSOR IMAGING; FEMALE; FLUORESCENCE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEURAL PATHWAYS; NEURONAVIGATION; OLIGODENDROGLIOMA; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955608608     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.10.JNS09447     Document Type: Article

References (23)

1. Bello L, Gallucci M, Fava M, Carrabba G, Giussani C, Acerbi F, et al: Intraoperative subcortical language tract mapping guides surgical removal of gliomas involving speech areas. Neurosurgery 60:67-82, 2007
2. Berger MS, Kincaid J, Ojemann GA, Lettich E: Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery 25:786-792, 1989
3. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30 (6 Suppl 19):10-14, 2003
4. Duffau H: Intraoperative cortico-subcortical stimulations in surgery of low-grade gliomas. Expert Rev Neurother 5:473-485, 2005
5. Duffau H: Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol 4:476-486, 2005
6. Feigl GC, Samii M, Horstmann GA: Volumetric follow-up of meningiomas: a quantitative method to evaluate treatment outcome of gamma knife radiosurgery. Neurosurgery 61:281-287, 2007
7. Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, et al: Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro-oncol 10:79-87, 2008
8. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, et al: Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 9:29-38, 2008
9. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H: 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. Swiss Med Wkly 138:180-185, 2008
10. Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-oncol 6:227-235, 2004
11. Liao H, Shimaya K, Wang K, Maruyama T, Noguchi M, Muragaki Y, et al: Combination of intraoperative 5-aminolevulinic acid-induced fluorescence and 3-D MR imaging for guidance of robotic laser ablation for precision neurosurgery. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 11:373-380, 2008
12. Mineo JF, Bordron A, Baroncini M, Ramirez C, Maurage CA, Blond S, et al: Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 149:245-253, 2007
13. Morofuji Y, Matsuo T, Hayashi Y, Suyama K, Nagata I: Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report. Neurosurgery 62 (3 Suppl 1):102-104, 2008
14. Noguchi M, Aoki E, Yoshida D, Kobayashi E, Omori S, Muragaki Y, et al: A novel robotic laser ablation system for precision neurosurgery with intraoperative 5-ALA-induced PpIX fluorescence detection. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 9:543-550, 2006
15. Ojemann JG, Ojemann GA, Lettich E: Cortical stimulation mapping of language cortex by using a verb generation task: effects of learning and comparison to mapping based on object naming. J Neurosurg 97:33-38, 2002
16. Stepp H, Beck T, Pongratz T, Meinel T, Kreth FW, Tonn JCh, et al: ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. J Environ Pathol Toxicol Oncol 26:157-164, 2007
17. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ: Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003-1013, 2000
18. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392-401, 2006
19. Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al: Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564-576, 2008
20. Stummer W, Reulen HJ, Novotny A, Stepp H, Tonn JC: Fluorescence-guided resections of malignant gliomas-an overview. Acta Neurochir Suppl 88:9-12, 2003
21. Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, et al: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518-526, 1998
22. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
23. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC: Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg 21:496-500, 2007